Entera Bio Ltd. Gains 35.17%
Fri, Jan 12, 2024 at 07:38 PM
Entera Bio Ltd. (ENTX:NASDAQ) soared at $1.09, representing a gain of 35.2%. On Fri, Jan 12, 2024, ENTX:NASDAQ touched a New 2-Week High of $1.09. The stock appeared on our News Catalysts scanner on Wed, Jan 03, 2024 at 09:58 AM in the 'MISCELLANEOUS' category. From Fri, Dec 29, 2023, the stock recorded 77.78% Up Days and 70.00% Green Days
About Entera Bio Ltd. (ENTX:NASDAQ)
Entera Bio Ltd is a biotechnology company specializing in the oral delivery of large molecules and biologics. It conducts clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics.
Top 10 Gainers:
- Applied UV Inc. (AUVI:NASDAQ), 67.11%
- Atreca, Inc. (BCEL:NASDAQ), 52.63%
- SRIVARU Holding Limited (SVMH:NASDAQ), 46.21%
- Vinco Ventures Inc. (BBIG:NASDAQ), 42.86%
- SYLA Technologies Co. Ltd. (SYT:NASDAQ), 36.1%
- Entera Bio Ltd. (ENTX:NASDAQ), 35.17%
- Nubia Brand International Corp. (NUBI:NASDAQ), 33.4%
- Cyclo Therapeutics Inc. (CYTH:NASDAQ), 30.99%
- Nuburu Inc. (BURU:NYSEMKT), 29.25%
- Elevation Oncology Inc. (ELEV:NASDAQ), 29.25%